11.28 USD
↗ 0.78 (7.43%)AT CLOSE (11:59 AM EDT)
REGENXBIO Inc.
RGNXNASDAQ • USD
11.43
↗ 0.15 (1.31%)
POST MARKET (AS OF 07:51 PM EDT)
Post Market
AS OF 07:51 PM EDT
11.43
↗ 0.15 (1.31%)
Market: CLOSED
RGNX is currently priced at $11.27. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, RGNX trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 6, 2026.
Open?$11.28
High?$11.50
Low?$10.85
Prev. Close?$10.50
Volume?1.8M
Avg. Volume?2.2M
VWAP?$11.12
Rel. Volume?0.81x
Bid / Ask
Bid?$11.36 × 1.0K
Ask?$11.50 × 100
Spread?$0.14
Midpoint?$11.43
Valuation & Ratios
Market Cap?672.2M
Shares Out?51.7M
Float?39.6M
Float %?76.5%
P/E Ratio?N/A
P/B Ratio?31.89
EPS?-$4.53
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
Themes
Employees
371
Market Cap
672.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2015-09-17
Address
9804 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
Phone: 240-552-8181
ROCKVILLE, MD 20850
Phone: 240-552-8181
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?5
Short Sent.?61
Piotroski F-Score?2/9Weak
Altman Z-Score?-5.54Distress
Confidence?58%Low
Short InterestSqueeze Risk
Short % of Float?21.81%Squeeze Risk
Short Interest?8.6M
Days to Cover?3.3
Free Float39.6M
Avg Daily Volume2.6M
Settlement Date2026-07-15
Financial Health
Current Ratio?2.62Strong
Quick Ratio?2.62Strong
Cash Ratio?0.21Low
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?31.89HIGH▾
Peers100
S&P3
P/S?7.65HIGH▾
Peers100
S&P14
P/FCF?N/A▾
EV/EBITDA?-2.7CHEAP▾
S&P97
EV/Sales?7.48HIGH▾
Peers100
S&P18
Returns & Efficiency
ROE?-1,375.6%WEAK▾
S&P3
ROA?-84.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-236403000
Enterprise Value?$657.0M
Fundamentals ratios updated end of day